- EN
Monitoring and analysing the nature and scale of the drugs phenomenon in Europe as well as the responses of Member States to the issue of drug use, is a central part of the EMCDDA's work. This section of the website provides access to the main EMCDDA outputs in this area.
In-depth discussion of the drug situation in Europe, by topic. This information is based on the EMCDDA's Annual report 2009.
The EMCDDA regularly publishes in-depth reviews of topical interest based on information provided as part of the national reporting process. These selected issues are available as PDFs.
The EMCDDA plays a key role in detecting and assessing new drugs through its action on new drugs activity. The findings of this work are published as part of the 'risk assessment' series. Recent outputs in this area can be found below:
The resources below all provide information, data and/or resources at a national level in Europe.
Detailed information and analyses on national drug-related legislation >>
Provides access to the current national strategies and action plans in Europe >>
Overviews of the availability of drug-related treatment (including social reintegration) >>
Assessing the many facets of the drug situation in Europe is a challenging task and a wide variety of methods and tools are employed by the EMCDDA in order to do this. Existing tools are being continously refined and improved, and new tools are developed as needs arise. The links below point to the main resources on the EMCDDA website which present methodological information. It should be noted that the categorisation used below is somewhat artificial as there is in fact some overlap between categories.